Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Jan 23;48(1):73.
doi: 10.1007/s10143-025-03206-9.

Delirium after deep brain stimulation for Parkinson's disease: a meta-analysis of incidence and risk factors

Affiliations
Meta-Analysis

Delirium after deep brain stimulation for Parkinson's disease: a meta-analysis of incidence and risk factors

Obai Yousef et al. Neurosurg Rev. .

Abstract

Deep brain stimulation (DBS) is a valuable treatment for Parkinson's disease (PD), but postoperative delirium (POD) is a common complication. Understanding the risk factors for POD is crucial for optimizing patient selection and developing preventative measures. This systematic review and meta-analysis aims to identify predictors of POD in PD patients undergoing DBS surgery. We conducted a comprehensive search of four major databases for cohort studies on POD in patients undergoing DBS for PD, up to June 2024. Two reviewers independently screened studies, assessed the risk of bias using the Newcastle-Ottawa Scale, and extracted data. Meta-analysis was conducted using Review Manager, with heterogeneity assessed the I2 statistic and chi-square p value. Subgroup and sensitivity analyses were also performed to explore the consistency of findings. Eleven studies, including 1,368 patients, were analyzed to determine the incidence of POD in PD patients undergoing DBS. The incidence of POD in PD patients undergoing DBS, which was found to be 21% (95% CI: [14.6%, 27.4%]). Age, Mini-Mental State Examination (MMSE), and Non-Motor Symptom Scale (NMSS) were significant predictors, with effect sizes of (OR = 1.10, 95% CI: [1.06, 1.15], P < 0.00001), (OR = 0.85, 95% CI: [0.72, 1.00], P = 0.05), and (OR = 1.01, 95% CI: [1.00, 1.02], P = 0.04), respectively. However, gender, UPDRS-III ON score, brain atrophy, diabetes, Hamilton Anxiety Score (HAMA), operation time, disease duration, BMI, and cerebral infarction were not significant predictors. This meta-analysis suggests that age, cognitive function, and non-motor symptoms are important factors associated with POD patients undergoing DBS surgery. Further research with larger sample sizes and diverse populations is needed to confirm these findings and identify more specific predictors.

Keywords: Deep brain stimulation; Delirium; Parkinsonism; Parkinson’s disease.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval: Not applicable. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW et al (2018) Prevalence of Parkinson’s disease across North America. Npj Park Dis 4:21. https://doi.org/10.1038/s41531-018-0058-0 - DOI
    1. Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R et al (2006) Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes. Mov Disord 21:S290–304. https://doi.org/10.1002/mds.20962 - DOI - PubMed
    1. Charles PD, Gill CE, Davis TL, Konrad PE, Benabid A-L (2008) Is deep brain stimulation neuroprotective if applied early in the course of PD? Nat Clin Pract Neurol 4:424–426. https://doi.org/10.1038/ncpneuro0848 - DOI - PubMed
    1. Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR et al (2018) Apomorphine subcutaneous infusion in patients with Parkinson’s disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol 17:749–759. https://doi.org/10.1016/S1474-4422(18)30239-4 - DOI - PubMed
    1. Fox SH, Katzenschlager R, Lim S, Barton B, De Bie RMA, Seppi K et al (2018) International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson’s disease. Mov Disord 33:1248–1266. https://doi.org/10.1002/mds.27372 - DOI - PubMed

LinkOut - more resources